Your browser doesn't support javascript.
loading
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.
Hall, Samuel A L; Burns, Gareth S; Anagnostou, Despina; Vogrin, Sara; Sundararajan, Vijaya; Ratnam, Dilip; Levy, Miriam T; Lubel, John S; Nicoll, Amanda J; Strasser, Simone I; Sievert, William; Desmond, Paul V; Ngu, Meng C; Angus, Peter; Sinclair, Marie; Meredith, Christopher; Matthews, Gail; Revill, Peter A; Jackson, Kathy; Littlejohn, Margaret; Bowden, D Scott; Locarnini, Stephen A; Visvanathan, Kumar; Thompson, Alexander J.
Afiliação
  • Hall SAL; Gastroenterology Department of St Vincent's Hospital Melbourne, Melbourne, Australia.
  • Burns GS; Department of Infectious Disease and Immunology Research Centre, St Vincent's Hospital, Melbourne, Australia.
  • Anagnostou D; Gastroenterology Department of St Vincent's Hospital Melbourne, Melbourne, Australia.
  • Vogrin S; Department of Infectious Disease and Immunology Research Centre, St Vincent's Hospital, Melbourne, Australia.
  • Sundararajan V; Gastroenterology Department of St Vincent's Hospital Melbourne, Melbourne, Australia.
  • Ratnam D; Department of Infectious Disease and Immunology Research Centre, St Vincent's Hospital, Melbourne, Australia.
  • Levy MT; Department of Infectious Disease and Immunology Research Centre, St Vincent's Hospital, Melbourne, Australia.
  • Lubel JS; The Department of Public Health, La Trobe University, Melbourne, Australia.
  • Nicoll AJ; Gastroenterology & Hepatology Unit, Monash Health, Melbourne, Australia.
  • Strasser SI; Monash University, Melbourne, Australia.
  • Sievert W; Gastroenterology Department of Liverpool Hospital, Sydney, Australia.
  • Desmond PV; Department of Gastroenterology, Alfred Health, Melbourne, Australia.
  • Ngu MC; Central Clinical School, Monash University, The Alfred Centre, Melbourne, Australia.
  • Angus P; Gastroenterology Department of Eastern Health, Melbourne, Australia.
  • Sinclair M; AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia.
  • Meredith C; University of Sydney, Sydney, Australia.
  • Matthews G; Gastroenterology & Hepatology Unit, Monash Health, Melbourne, Australia.
  • Revill PA; Monash University, Melbourne, Australia.
  • Jackson K; Gastroenterology Department of St Vincent's Hospital Melbourne, Melbourne, Australia.
  • Littlejohn M; Gastroenterology Department of Concord Repatriation General Hospital, Sydney, Australia.
  • Bowden DS; Department of Gastroenterology & Hepatology, Austin Health, Melbourne, Australia.
  • Locarnini SA; University of Melbourne, Melbourne, Australia.
  • Visvanathan K; Department of Gastroenterology & Hepatology, Austin Health, Melbourne, Australia.
  • Thompson AJ; Gastroenterology Department of Bankstown-Lidcombe Hospital, Sydney, Australia.
Aliment Pharmacol Ther ; 56(2): 310-320, 2022 07.
Article em En | MEDLINE | ID: mdl-35521992

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Antígenos de Superfície da Hepatite B Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Antígenos de Superfície da Hepatite B Idioma: En Ano de publicação: 2022 Tipo de documento: Article